In this episode of Exploration Science, Dr. David Shoultz,
Chief Operating Officer & Co-Founder of Monod Bio discusses the next
generation of clinical diagnostics and how the company is transforming point of
care for patients. Tune in and learn how scientists at Monod Bio are driving
diagnostic innovation through de novo protein design and
deploying lucCage technology. This platform is based on research conducted
by Dr. David Baker and scientists at the University of Washington Institute for
Protein Design to generate artificial luciferases with optimized size,
stability, substrate specificity, and photophysical properties.
